AC Immune S.A. (ACIU) vs EyePoint Pharmaceuticals, Inc. (EYPT)
A side-by-side comparison of AC Immune S.A. and EyePoint Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ACIU
AC Immune S.A.
$2.56HealthcareDelayed quote: Oct 6, 2026, 12:45 PM EDT
EYPT
EyePoint Pharmaceuticals, Inc.
$3.18HealthcareDelayed quote: Oct 6, 2026, 12:45 PM EDT
Total return — ACIU vs EYPT
growth of $100 · dividends reinvested · last 10yACIU -83.1% (-16.3%/yr)EYPT -89.5% (-20.2%/yr)ACIU compounded faster over this window
ACIU EYPT
ACIU vs EYPT: by the numbers
- •EYPT is the larger company ($267M vs $260M market cap).
- •Both run net losses; ACIU's is the smaller (-249.94% vs -10994.73% net margin).
- •Both shrank revenue over the past five years; ACIU's decline was smaller (-23.70% vs -41.05% CAGR).
Metrics side by side
Valuation
| Metric | ACIU | EYPT |
|---|---|---|
| P/S ratio | 11.98 | 95.64 |
| P/B ratio | 5.98 | 1.60 |
Profitability
| Metric | ACIU | EYPT |
|---|---|---|
| Gross margin | 100.00% | 93.41% |
| Operating margin | -1927.32% | -775.98% |
| Net margin | -249.94% | -10994.73% |
| ROE | -124.67% | -184.27% |
| ROIC | -89.43% | -170.19% |
Growth (annualized)
| Metric | ACIU | EYPT |
|---|---|---|
| Revenue CAGR (5Y) | -23.70% | -41.05% |
| Total return CAGR (5Y) | -16.03% | -21.68% |
Frequently asked
- Which has grown faster, ACIU or EYPT?
- Neither grew: over the past five years both shrank revenue, with ACIU's decline the smaller — ACIU at a -23.70% CAGR versus EYPT at -41.05%.
- How have ACIU and EYPT total returns compared?
- Over the past 10 years, ACIU delivered -16.61% and EYPT delivered -20.02% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.